Does losing family members in midlife matter for late-life mental and cognitive health? A longitudinal study of older Swedes spanning 30 years
CONCLUSION: Midlife bereavement might have gendered implications on LLD and cognitive impairment, but associations need to be confirmed by well-powered studies. Further research is warranted to elucidate the association between multiple midlife losses and reduced LLD risk.PMID:38644675 | DOI:10.1080/13607863.2024.2341877 (Source: Aging and Mental Health)
Source: Aging and Mental Health - April 22, 2024 Category: Geriatrics Authors: Valeria Cecchini Neda Agahi Source Type: research
Cell death as an architect of adult skin stem cell niches
Cell Death Differ. 2024 Apr 22. doi: 10.1038/s41418-024-01297-3. Online ahead of print.ABSTRACTOur skin provides a physical and immunological barrier against dehydration and environmental insults ranging from microbial attacks, toxins and UV irradiation to wounding. Proper functioning of the skin barrier largely depends on the interplay between keratinocytes- the epithelial cells of the skin- and immune cells. Two spatially distinct populations of keratinocyte stem cells (SCs) maintain the epidermal barrier function and the hair follicle. These SCs are inherently long-lived, but cell death can occur within their niches and...
Source: Cancer Control - April 22, 2024 Category: Cancer & Oncology Authors: Kim Lecomte Annagiada Toniolo Esther Hoste Source Type: research
The effects of jujube (Ziziphus jujube) on metabolic and mental health outcomes in patients with metabolic syndrome: A randomized controlled trial
CONCLUSION: Jujube consumption only had beneficial effects on WC, TG, and HDL-C in subjects with MetS. However, the current study has methodological weaknesses in blinding and herb purity/potency testing, which should be addressed in future studies.TRIAL REGISTRATION: Iranian Registry of Clinical Trials (registration number: IRCT20180201038585N10; registration date: 11 April 2021), https://www.irct.ir/trial/55287.PMID:38648942 | DOI:10.1016/j.ctim.2024.103041 (Source: Complementary Therapies in Medicine)
Source: Complementary Therapies in Medicine - April 22, 2024 Category: Complementary Medicine Authors: Karim Parastouei Saad Badai Nashtar Zaid Al-Attar Parivash Shekarchizadeh-Esfahani Gholamreza Askari Source Type: research
Canadian Network for Mood and Anxiety Treatments (CANMAT) 2023: Towards Personalized Approaches to Depression Treatment
Can J Psychiatry. 2024 Apr 22:7067437241248087. doi: 10.1177/07067437241248087. Online ahead of print.NO ABSTRACTPMID:38644770 | DOI:10.1177/07067437241248087 (Source: Canadian Journal of Psychiatry)
Source: Canadian Journal of Psychiatry - April 22, 2024 Category: Psychiatry Authors: Michael Berk Bruno Agustini Malcolm Forbes Felice N Jacka Janardhanan C Narayanaswamy Brenda W J H Penninx Source Type: research
A Service ‐Led Pragmatic Evaluation of Family Foundations Targeting the Reduction of Perinatal Parent Mental Health Difficulties and Family Conflict in Australia
ABSTRACTA service-led evaluation of home-based Family Foundations (FF), a perinatal intervention targeting interparental conflict and mental health difficulties, was conducted in Melbourne, Australia. The aims were to assess (a) pre –post intervention changes, (b) parent satisfaction and (c) intervention fidelity. Participants included 288 families who completed self-report surveys, and FF clinicians who completed fidelity checklists. Approximately 78% of families who commenced FF completed all 10 sessions. High parent satisf action and intervention fidelity were reported. For Parent 1s (primarily mothers), there were re...
Source: Child and Family Social Work - April 22, 2024 Category: Child Development Authors: Rebecca Giallo,
Grace McMahon,
Madison Schulz,
Alison Fogarty,
Monique Seymour,
Casey Hosking,
Helen Findley,
Carolyn Wallace,
Samantha Bladon,
Mark Feinberg Tags: ORIGINAL ARTICLE Source Type: research
The translocator protein 18kDa ligand etifoxine in the treatment of depressive disorders —a double-blind, randomized, placebo-controlled proof-of-concept study
Recent developments suggest that neurosteroids may achieve rapid antidepressant effects. As such, neurosteroidogenesis mediated by the translocator protein 18 kDa (TSPO) might constitute a promising option for... (Source: Trials)
Source: Trials - April 22, 2024 Category: General Medicine Authors: Lisa-Marie Brunner, Marco Riebel, Simon Wein, Michael Koller, Florian Zeman, Gunnar Huppertz, Tanja Emmer, Yvonne Eberhardt, Jens Schwarzbach, Rainer Rupprecht and Caroline Nothdurfter Tags: Study protocol Source Type: research
Impact of COVID-19 pandemic on depression incidence and healthcare service use among patients with depression: an interrupted time-series analysis from a 9-year population-based study
Most studies on the impact of the COVID-19 pandemic on depression burden focused on the earlier pandemic phase specific to lockdowns, but the longer-term impact of the pandemic is less well-studied. In this po... (Source: BMC Medicine)
Source: BMC Medicine - April 22, 2024 Category: Internal Medicine Authors: Vivien Kin Yi Chan, Yi Chai, Sandra Sau Man Chan, Hao Luo, Mark Jit, Martin Knapp, David Makram Bishai, Michael Yuxuan Ni, Ian Chi Kei Wong and Xue Li Tags: Research article Source Type: research
Clusters of lifestyle behavioral risk factors and their associations with depressive symptoms and stress: evidence from students at a university in Finland
No previous research of university students in Finland assessed lifestyle behavioral risk factors (BRFs), grouped students into clusters, appraised the relationships of the clusters with their mental well-bein... (Source: BMC Public Health)
Source: BMC Public Health - April 22, 2024 Category: Consumer Health News Authors: Walid El Ansari, Rene Sebena, Kareem El-Ansari and Sakari Suominen Tags: Research Source Type: research
Maternal depressive symptoms and mother-infant co-sleeping (including room sharing and bedsharing): a systematic review
Journal of Clinical Sleep Medicine, Ahead of Print. (Source: Journal of Clinical Sleep Medicine : JCSM)
Source: Journal of Clinical Sleep Medicine : JCSM - April 22, 2024 Category: Sleep Medicine Authors: Elaine S. Barry
Levita D ’Souza
1Human Development and Family Studies, The Pennsylvania State University, Fayette
2Faculty of Education, Monash University Source Type: research
Psychological Aspects of Facial Palsy
This article discusses the psychological effects of facial palsy (FP) in adults. FP is the abnormal functioning of facial muscles resulting from temporary or permanent damage of the facial nerves. Following facial paralysis, patients can develop motor and psychosocial functioning issues impacting quality of life. In addition, real or perceived judgment in social settings of those with FP increases the risk of low self-esteem, anxiety, and depression. Currently, most available research focuses on surgical patients and suggests a lack of psychological support throughout the affliction. A multidisciplinary approach when treat...
Source: Facial Plastic Surgery - April 22, 2024 Category: Cosmetic Surgery Authors: Shamil, Eamon Noriega, Maria Moin, Sarah Ko, Tsz Ki Tan, Denise Jia Yun Meller, Catherine Andrews, Peter Lekakis, Garyfalia Tags: Original Article Source Type: research
Self-esteem, depression, anxiety and sexual function in Mayer-Rokitansky-K üster-Hauser syndrome with neovagina: A case series
The Mayer-Rokitansky-K üster-Hauser (MRKH) syndrome is a rare congenital disorder which affects one out of 4000 to 5000 women [1]. Due to failed embryologic development of the Müllerian ducts, the uterus and vagina are absent in women with MRKH syndrome. Patients are usually diagnosed during adolescence because of the a bsence of menstruation [2] or when difficulties with vaginal intercourse or infertility are experienced [3,4]. MRKH syndrome is traditionally classified into two types: Type I (isolated) without other malformations, Type II (atypical) includes renal and adnexal malformations and Müllerian agenesis, renal...
Source: European Journal of Obstetrics, Gynecology, and Reproductive Biology - April 22, 2024 Category: OBGYN Authors: Xiao-hong Lei, Xiao Wang, Shu-yi Shao, Ke-qin Hua, Ying Zhang Tags: Full length article Source Type: research
Comment on “Adherence to the ultra-processed dietary pattern and risk of depressive outcomes: findings from the NutriNet Brasil cohort study and an updated systematic review and meta-analysis” Clinical Nutrition
(Source: Clinical Nutrition ESPEN)
Source: Clinical Nutrition ESPEN - April 22, 2024 Category: Nutrition Authors: Ana Patr ícia da Silva Souza, Sandra Lopes de Souza, José Maurício Lucas da Silva, Mayara Luclécia da Silva, Waleska Maria Almeida Barros Source Type: research
The association between depressive symptoms and executive function in type 1 diabetes population: A scoping review
The purpose of this study was to explore the existing literature on the relationship between depressive symptoms and executive function in patients with type 1 diabetes (T1DM) across the lifespan. (Source: Primary Care Diabetes)
Source: Primary Care Diabetes - April 22, 2024 Category: Primary Care Authors: Chawisa Dandamrongrak, Kaitlyn Rechenberg, Jumpee Granger, Ayesha Johnson, Kailei Yan, Jennifer Kue Source Type: research
Hearing Difficulties Among Farmworkers in the M éxico-US Southwest Border Region
This report contributes to understanding the perception of hearing-related health and occupational exposures among farmworkers in the México-US Southwest border region. The i nformation from this line of research will inform appropriate safety measures known to lower the risk of experiencing occupational NIHL. (Source: Journal of Immigrant and Minority Health)
Source: Journal of Immigrant and Minority Health - April 22, 2024 Category: International Medicine & Public Health Source Type: research
Efficacy and safety of aticaprant, a kappa receptor antagonist, adjunctive to oral SSRI/SNRI antidepressant in major depressive disorder: results of a phase 2 randomized, double-blind, placebo-controlled study
Neuropsychopharmacology, Published online: 22 April 2024; doi:10.1038/s41386-024-01862-xEfficacy and safety of aticaprant, a kappa receptor antagonist, adjunctive to oral SSRI/SNRI antidepressant in major depressive disorder: results of a phase 2 randomized, double-blind, placebo-controlled study (Source: Neuropsychopharmacology)
Source: Neuropsychopharmacology - April 22, 2024 Category: Neurology Authors: Mark E. Schmidt Iva Kezic Vanina Popova Rama Melkote Peter Van Der Ark Darrel J. Pemberton Guy Mareels Carla M. Canuso Maurizio Fava Wayne C. Drevets Source Type: research
